FBIO: Fortress Biotech Inc

FBIO新闻

• 05:57 Fortress Biotech, Inc. (FBIO) Q2 2026 Earnings Call Transcript
• 17:50 Fortress Biotech: Cash Above Market Cap And Royalty Upside Make This A Speculative Buy
• 21:20 Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)
• 13:05 Avenue Therapeutics licenses ATX-04 for Pompe disease treatment
• 02:38 Fortress Biotech Stock: The PRV Catalyst That Could Reprice This Microcap (NASDAQ:FBIO)
• 17:56 Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes
• 17:21 Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums
• 18:29 Centene Expands Palliative Care Access in Ohio Through Tuesday Health
• 22:14 FDA批准首个儿童门克斯病治疗方法
• 22:13 FDA approves first treatment for Menkes disease in children
• 13:54 FDA为Fortress Biotech的门克斯病疗法设定新PDUFA日期
• 13:47 FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy
• 12:44 堡垒生物科技公司重新提交门克斯病治疗药物新药申请
• 14:40 Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates
• 03:41 Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript
• 22:25 Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
• 13:15 Kamada (KMDA) Misses Q3 Earnings Estimates
• 22:45 Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
• 22:15 Ultragenyx (RARE) Reports Q3 Loss, Misses Revenue Estimates
• 22:14 Turn Therapeutics任命Andrew Scott为企业传讯副总裁
• 12:15 Apellis Pharmaceuticals, Inc. (APLS) Q3 Earnings and Revenues Top Estimates